Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,813-1,824 of 6,115
Drug study icon
Active Not RecruitingNCT06941844

Study of DT120 for Major Depressive Disorder (Emerge)

This study is active but not recruiting in the United States. It focuses on depression.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Behavioral study icon
CompletedNCT00377299

Citicoline add-on Therapy for depression

This study is completed in the United States. It is testing Citicoline add-on Therapy for depression.

In Dallas
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT03774641

A Study of Prophylactic Management of Lamotrigine in Pregnant Women

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression, Bipolarity
Device study icon
Active Not RecruitingNCT07102017

A Controlled study of Robotic Support for Enhanced Later Life (RoSELL)

This study is active but not recruiting in China. It focuses on Depression.

In Shanghai
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 65 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Depression
Drug study icon
CompletedNCT01941043

CERC-301 for depression

This study is completed in the United States. It is testing CERC-301 for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Avalo Therapeutics, Inc.
Condition
Depression, Suicidality
Drug study icon
CompletedNCT02476058

Safety study of JNJ-42847922 in depression

This study is completed in Belgium, in Germany, and in the Netherlands. It is testing JNJ-42847922 for depression.

Multiple locations, including Aalst
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
Belgium, Germany, Netherlands
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
CompletedNCT00095758

Adjunctive Aripiprazole in people with Major Depressive Disorder

This study is completed in the United States. It is testing aripiprazole for depression.

Multiple locations, including Beverly Hills
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.